Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Indaptus Therapeutics, Inc. (INDP) had Normalized Income after Taxes of $-2.54M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.54M |
|
-- |
|
-- |
|
$2.16M |
|
$-2.16M |
|
$-0.38M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
|
Normalized Income after Taxes |
$-2.54M |
$-2.16M |
|
$-2.16M |
|
10.96M |
|
10.96M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$2.18M |
|
-- |
|
-- |
|
$2.18M |
|
$0.93M |
|
-- |
|
-- |
|
$0.93M |
|
$1.25M |
|
$1.25M |
|
$1.25M |
|
113.24M |
|
| Cash Flow Statement Financials | |
$-7.01M |
|
-- |
|
-- |
|
$8.51M |
|
$1.50M |
|
$-7.01M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-203.63% |
|
-203.63% |
|
-116.52% |
|
-203.63% |
|
$0.01 |
|
$-0.64 |
|
$-0.64 |
|